Related references
Note: Only part of the references are listed.A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode α-carbonic anhydrases
Letizia Crocetti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
PRECLINICAL DRUG TRIALS IN THE mdx MOUSE: ASSESSMENT OF RELIABLE AND SENSITIVE OUTCOME MEASURES
Christopher F. Spurney et al.
MUSCLE & NERVE (2009)
Free radicals and muscle fatigue: Of ROS, canaries, and the IOC
Michael B. Reid
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Increased treatment options for Duchenne and related muscular dystropies
D. J. Wells
GENE THERAPY (2008)
External pH influences the transcriptional profile of the carbonic anhydrase, CAH-4b in Caenorhabditis elegans
Rebecca A. Hall et al.
MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2008)
Caenorhabditis elegans in Parkinson's Disease Drug Discovery: Addressing an Unmet Medical Need
Richard Nass et al.
MOLECULAR INTERVENTIONS (2008)
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy
Miranda D. Grounds et al.
NEUROBIOLOGY OF DISEASE (2008)
New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials
Giulio Cossu et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Gene therapy for Duchenne muscular dystrophy - Expectations and challenges
Louise R. Rodino-Klapac et al.
ARCHIVES OF NEUROLOGY (2007)
Invertebrate animal models of diseases as screening tools in drug discovery
Laurent Segalat
ACS CHEMICAL BIOLOGY (2007)
N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans
Michael J. McKenna et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Finding function in novel targets:: C-elegans as a model organism
T Kaletta et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?
P Miura et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Blocking of striated muscle degeneration by serotonin in C-Elegans
Maite Carre-Pierrat et al.
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2006)
MUSCLE: multiple sequence alignment with high accuracy and high throughput
RC Edgar
NUCLEIC ACIDS RESEARCH (2004)
A conserved siRNA-degrading RNase negatively regulates RNA interference in C-elegans
S Kennedy et al.
NATURE (2004)
Functional implications of a novel EA2 mutation in the P/Q-type calcium channel
SD Spacey et al.
ANNALS OF NEUROLOGY (2004)
Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects
S Pastorekova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2004)
Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans
A Gaud et al.
NEUROMUSCULAR DISORDERS (2004)
Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse
A Briguet et al.
NEUROMUSCULAR DISORDERS (2004)
Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic Mdx mice
P Dunant et al.
MOLECULAR THERAPY (2003)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)
Inhibition of muscle carbonic anhydrase slows the Ca2+ transient in rat skeletal muscle fibers
P Wetzel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies
TA Rando
MUSCLE & NERVE (2001)
Muscular degeneration in the absence of dystrophin is a calcium-dependent process
MC Mariol et al.
CURRENT BIOLOGY (2001)
Identification of subtypes of muscarinic receptors that regulate Ca2+ and K+ channel activity in sympathetic neurons
MS Shapiro et al.
LIFE SCIENCES (2001)
Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans
K Gieseler et al.
CURRENT BIOLOGY (2000)